EA200800205A1 - Кальций-пептидный компонент - Google Patents

Кальций-пептидный компонент

Info

Publication number
EA200800205A1
EA200800205A1 EA200800205A EA200800205A EA200800205A1 EA 200800205 A1 EA200800205 A1 EA 200800205A1 EA 200800205 A EA200800205 A EA 200800205A EA 200800205 A EA200800205 A EA 200800205A EA 200800205 A1 EA200800205 A1 EA 200800205A1
Authority
EA
Eurasian Patent Office
Prior art keywords
peptide component
calcium
calcium peptide
caseinophosphopeptide
glycomacropeptide
Prior art date
Application number
EA200800205A
Other languages
English (en)
Other versions
EA016259B1 (ru
Inventor
Марко Зелль
Дирк Боде
Гюнтер Заватцки
Original Assignee
Хумана Мильхунион Эг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хумана Мильхунион Эг filed Critical Хумана Мильхунион Эг
Publication of EA200800205A1 publication Critical patent/EA200800205A1/ru
Publication of EA016259B1 publication Critical patent/EA016259B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

В заявке описан кальций-пептидный компонент, получаемый по меньшей мере из одной кальциевой соли, казеинофосфопептида и гликомакропептида. Тем самым удается использовать присущий молоку принцип, состоящий в связывании больших количеств кальция с белками.
EA200800205A 2005-07-19 2006-05-31 Применение кальций-пептидного компонента для снижения веса тела EA016259B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005033630A DE102005033630A1 (de) 2005-07-19 2005-07-19 Calcium-Peptid-Komponente
PCT/EP2006/005173 WO2007009529A2 (de) 2005-07-19 2006-05-31 Calcium-peptid-komponente

Publications (2)

Publication Number Publication Date
EA200800205A1 true EA200800205A1 (ru) 2008-08-29
EA016259B1 EA016259B1 (ru) 2012-03-30

Family

ID=37575596

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200800205A EA016259B1 (ru) 2005-07-19 2006-05-31 Применение кальций-пептидного компонента для снижения веса тела

Country Status (5)

Country Link
EP (1) EP1903895A2 (ru)
DE (1) DE102005033630A1 (ru)
EA (1) EA016259B1 (ru)
UA (1) UA94716C2 (ru)
WO (1) WO2007009529A2 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
DE102006052560B4 (de) * 2006-11-06 2010-01-21 Humana Milchunion Eg Anti-diabetogene Calcium-Peptid-Zusammensetzung
DE102007022694A1 (de) 2007-05-11 2008-11-13 Humana Milchunion Eg Milchfett-Milchprotein-Zusammensetzung zur Verbesserung der Calcium-Aufnahme
WO2010098822A1 (en) 2009-02-24 2010-09-02 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
WO2011137249A1 (en) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
CN103445045A (zh) * 2012-05-30 2013-12-18 孔徐生 一种具有促进钙吸收功能的组合物及其制备方法
CN109805417A (zh) * 2019-03-01 2019-05-28 河南九九一生物科技有限公司 一种能够增加骨密度的保健食品及其加工方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3373544B2 (ja) * 1991-12-05 2003-02-04 明治乳業株式会社 月経困難症を緩和する効果のある、カルシウム利用性に優れた飲食品及び医薬品
GB9927603D0 (en) * 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
RU2268069C2 (ru) * 2000-04-18 2006-01-20 Сосьете Де Продюи Нестле С.А. Питательные модули
US6384087B1 (en) * 2000-09-01 2002-05-07 University Of Tennesseee Research Corporation, Inc. Materials and methods for the treatment or prevention of obesity
GB0100273D0 (en) * 2001-01-08 2001-02-14 Nestle Sa Nutritional composition for a bone condition
US20030165574A1 (en) * 2002-03-01 2003-09-04 Ward Loren Spencer Compositions and methods for treatment of body weight conditions
JP2003048843A (ja) * 2002-07-17 2003-02-21 Meiji Milk Prod Co Ltd 月経困難症の予防及び／又は治療用機能性食品

Also Published As

Publication number Publication date
WO2007009529A2 (de) 2007-01-25
WO2007009529A3 (de) 2007-06-28
EP1903895A2 (de) 2008-04-02
EA016259B1 (ru) 2012-03-30
DE102005033630A1 (de) 2007-01-25
UA94716C2 (ru) 2011-06-10

Similar Documents

Publication Publication Date Title
DE602005008996D1 (de) Radiofluorierte peptide
EA200800205A1 (ru) Кальций-пептидный компонент
EA201001223A1 (ru) Стабилизированные белковые композиции
ATE428727T1 (de) Neue, an den erythropoietinrezeptor bindende peptide
DE602006018856D1 (de) Neue nutrazeutika-zusammensetzungen
DE602005012555D1 (de) Künstliches protein zur absoluten quantifizierung von proteinen und verwendungen davon
EA200801621A1 (ru) Антитела, направленные на her-3, и их применение
ATE482281T1 (de) Plastiden transit peptide
DE602005021970D1 (de) Verwendung von peptidverbindungen zur behandlung von schmerzen durch knochenkrebs, chemotherapie- und nucleosid-bedingten schmerzen
EA201491049A1 (ru) Противораковый слитый белок
CY1116269T1 (el) Χρηση μιας πρωτεϊνης απο λουπινο
MX2008000230A (es) Proteinas de enlace il-6.
IS8308A (is) Amínósýrur með sækni fyrir a2o prótíninu
ATE492284T1 (de) Behandlung von chronischen nierenerkrankungen mit lanthanum-verbindungen
DE602005013650D1 (de) Proteinhydrolysat zur behandlung von müdigkeit
ATE394123T1 (de) Flüssige formulierungen des tumornekrosefraktor- bindungsproteins tbp-1
EA200800109A1 (ru) Суправалентные соединения
EA200702353A1 (ru) Белковые гидролизаты, снижающие кровяное давление
EA200701892A1 (ru) Композиции, содержащие связанную воду и компоненты, помещённые в водочувствительную основу
DE602004023624D1 (de) Antimikrobielle peptide
ATE485831T1 (de) Behandlung von neurodegeneration
ATE419271T1 (de) Antimikrobielle peptide
RU2007100727A (ru) Керамическая масса
ITRM20050045A1 (it) Proteina isolata da eisenia foetida simile all'ngf umano e usi relativi.
EA200600956A1 (ru) Молекулы-антагонисты цитокинов

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU